A phase 1 trial of ONO-4578 in hormone receptor-positive, HER2-negative breast cancer
Latest Information Update: 08 Dec 2021
At a glance
- Drugs ONO 4578 (Primary)
- Indications HER2 negative breast cancer
- Focus Adverse reactions
- 08 Dec 2021 New trial record